The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
IGF2 and cancer
Abstract
Insulin-like growth factor 2 (IGF2) is a 7.5 kDa mitogenic peptide hormone expressed by liver and many other tissues. It is three times more abundant in serum than IGF1, but our understanding of its physiological and pathological roles has lagged behind that of IGF1. Expression of the IGF2 gene is strictly regulated. Over-expression occurs in many cancers and is associated with a poor prognosis. Elevated serum IGF2 is also associated with increased risk of developing various cancers including colorectal, breast, prostate and lung. There is established clinical utility for IGF2 measurement in the diagnosis of non-islet cell tumour hypoglycaemia, a condition characterised by a molar IGF2:IGF1 ratio >10. Recent advances in understanding of the pathophysiology of IGF2 in cancer have suggested much novel clinical utility for its measurement. Measurement of IGF2 in blood and genetic and epigenetic tests of the IGF2 gene may help assess cancer risk and prognosis. Further studies will determine whether these tests enter clinical practice. New therapeutic approaches are being developed to target IGF2 action. This review provides a clinical perspective on IGF2 and an update on recent research findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gualberto, A., Hixon, M. L., Karp, D. D., Li, D., Green, S., Dolled-Filhart, M. P., Paz-Ares, L. G., Novello, S., Blakely, J., Langer, C. J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605972 · Cited by 85
RetractedBi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor
Entingh, A. J., Taniguchi, C. M., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303056200 · Cited by 59
RetractedInsulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
Kornfeld, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.001515 · Cited by 1,092
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Insulin‐like growth factors I and II
HUMBEL, R. E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15595.x · Cited by 999
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044383 · Cited by 938
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Birth Defects Original Article Series: Wilson's Disease
ENGEL, A. G. (1970) · Neurology · doi:10.1212/wnl.20.5.523-a · Cited by 893
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Somatomedin: Proposed Designation for Sulphation Factor
DAUGHADAY, W. H., HALL, K., RABEN, M. S., SALMON, W. D., LEO VAN DEN BRANDE, J., & VAN WYK, J. J. (1972) · Nature · doi:10.1038/235107a0 · Cited by 842
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Gli and hedgehog in cancer: tumours, embryos and stem cells
Ruiz i Altaba, A., Sánchez, P., & Dahmane, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc796 · Cited by 708
Zapf, J., Walter, H., & Froesch, E. R. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110379 · Cited by 595
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202766200 · Cited by 500
Insulin-like growth factor binding proteins and their role in controlling IGF actions
Clemmons, D. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00053-6 · Cited by 498
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
Kelley, K. M., Oh, Y., Gargosky, S. E., Gucev, Z., Matsumoto, T., Hwa, V., Ng, L., Simpson, D. M., & Rosenfeld, R. G. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00005-2 · Cited by 479
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
Froesch, E. R., Bürgi, H., Ramseier, E. B., Bally, P., & Labhart, A. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104866 · Cited by 419
Role of insulin-like growth factor binding proteins in controlling IGF actions
Clemmons, D. R. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00024-0 · Cited by 392
The proliferating role of insulin and insulin-like growth factors in cancer
Gallagher, E. J., & LeRoith, D. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.007 · Cited by 380
Sparago, A., Cerrato, F., Vernucci, M., Ferrero, G. B., Silengo, M. C., & Riccio, A. (2004) · Nature Genetics · doi:10.1038/ng1410 · Cited by 371
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Soubry, A., Schildkraut, J. M., Murtha, A., Wang, F., Huang, Z., Bernal, A., Kurtzberg, J., Jirtle, R. L., Murphy, S. K., & Hoyo, C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-29 · Cited by 354
Daughaday, W. H., Emanuele, M. A., Brooks, M. H., Barbato, A. L., Kapadia, M., & Rotwein, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812013192202 · Cited by 351
Transactivation of Igf2 in a mouse model of Beckwith–Wiedemann syndrome
Sun, F.-L., Dean, W. L., Kelsey, G., Allen, N. D., & Reik, W. (1997) · Nature · doi:10.1038/39797 · Cited by 332
The Link between the Metabolic Syndrome and Cancer
Braun, S., Bitton-Worms, K., & LeRoith, D. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1003 · Cited by 326
Harrela, M., Koistinen, H., Kaprio, J., Lehtovirta, M., Tuomilehto, J., Eriksson, J., Toivanen, L., Koskenvuo, M., Leinonen, P., Koistinen, R., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119081 · Cited by 323
Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum
Frystyk, J., Skjærbæk, C., Dinesen, B., & Ørskov, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00602-4 · Cited by 306
Frystyk, J., Skjærbæk, C., Vestbo, E., Fisker, S., & Ørskov, H. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e · Cited by 304
Molecules in focus Insulin-like growth factor II (IGF-II)
O'Dell, S. D., & Day, I. N. M. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00048-x · Cited by 304
Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse
Susiarjo, M., Sasson, I., Mesaros, C., & Bartolomei, M. S. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003401 · Cited by 291
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Gualberto, A., & Pollak, M. (2009) · Oncogene · doi:10.1038/onc.2009.172 · Cited by 274
Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., & Hintz, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36715-7 · Cited by 272
Belfiore, A., & Malaguarnera, R. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0074 · Cited by 272
Boisclair, Y., Rhoads, R., Ueki, I., Wang, J., & Ooi, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700063 · Cited by 267
Insulin resistance and cancer: The role of insulin and IGFs
Djiogue, S., Nwabo Kamdje, A. H., Vecchio, L., Kipanyula, M. J., Farahna, M., Aldebasi, Y., & Seke Etet, P. F. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0324 · Cited by 263
Role of insulin-like growth factor 1 receptor signalling in cancer
Larsson, O., Girnita, A., & Girnita, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602627 · Cited by 246
Expression of insulin-like growth factor-1 receptor in human colorectal cancer
Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., & Coppola, D. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90027-8 · Cited by 239
Chen, C., Mahalingam, D., Osmulski, P., Jadhav, R. R., Wang, C., Leach, R. J., Chang, T., Weitman, S. D., Kumar, A. P., Sun, L., et al. (2013) · The Prostate · doi:10.1002/pros.22625 · Cited by 239
Vella, V. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.245 · Cited by 239
Oh, Y., Müller, H. L., Ng, L., & Rosenfeld, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13589 · Cited by 237
Patched Target Igf2 Is Indispensable for the Formation of Medulloblastoma and Rhabdomyosarcoma
Hahn, H., Wojnowski, L., Specht, K., Kappler, R., Calzada-Wack, J., Potter, D., Zimmer, A., Müller, U., Samson, E., Quintanilla-Martinez, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000352200 · Cited by 233
Promoter-specific imprinting of the human insulin-like growth factor-II gene
Vu, T. H., & Hoffman, A. R. (1994) · Nature · doi:10.1038/371714a0 · Cited by 227
Non-Islet Cell Tumour-Induced Hypoglycaemia: A Review of the Literature Including Two New Cases
de Groot, J. W. B., Rikhof, B., van Doorn, J., Bilo, H. J. G., Alleman, M. A., Honkoop, A. H., & van der Graaf, W. T. A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0161 · Cited by 222
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
Maki, R. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5040 · Cited by 218
CLEMMONS, D. R., SNYDER, D. K., & BUSBY, W. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-727 · Cited by 214
Kim, K., Bae, S. K., Lee, O., Bae, M.-H., Lee, M. J., & Park, B. C. (1998) · PubMed · Cited by 190
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II)
Bates, P., Fisher, R., Ward, A., Richardson, L., Hill, D., & Graham, C. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.484 · Cited by 187
Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda, I., Hizuka, N., Ishikawa, Y., Yasumoto, K., Murakami, Y., Sata, A., Morita, J., Kurimoto, M., Okubo, Y., & Takano, K. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.05.003 · Cited by 186
Yu, H., Mistry, J., Nicar, M. J., Khosravi, M. J., Diamandis, A., van Doorn, J., & Juul, A. (1999) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(1999)13:4<166::aid-jcla5>3.0.co;2-x · Cited by 186
Algire, C., Amrein, L., Bazile, M., David, S., Zakikhani, M., & Pollak, M. (2011) · Oncogene · doi:10.1038/onc.2010.483 · Cited by 181
Does intentional weight loss reduce cancer risk?
Byers, T., & Sedjo, R. L. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01464.x · Cited by 177
Zapf, J., Futo, E., Peter, M., & Froesch, E. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116152 · Cited by 172
Rinderknecht, E., & Humbel, R. E. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4379 · Cited by 165
Sciacca, L., Mineo, R., Pandini, G., Murabito, A., Vigneri, R., & Belfiore, A. (2002) · Oncogene · doi:10.1038/sj.onc.1206058 · Cited by 162
IGF2 DNA methylation is a modulator of newborn’s fetal growth and development
St-Pierre, J., Hivert, M.-F., Perron, P., Poirier, P., Guay, S.-P., Brisson, D., & Bouchard, L. (2012) · Epigenetics · doi:10.4161/epi.21855 · Cited by 158
Single Nucleotide Polymorphisms
(2009) · Methods in molecular biology · doi:10.1007/978-1-60327-411-1 · Cited by 152
Vidal, A. C., Murphy, S. K., Murtha, A. P., Schildkraut, J. M., Soubry, A., Huang, Z., Neelon, S. E. B., Fuemmeler, B. F., Iversen, E. S., Wang, F., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.47 · Cited by 150
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
Perks, C. M., Vernon, E. G., Rosendahl, A. H., Tonge, D. W., & Holly, J. M. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210397 · Cited by 143
Lahm, H., Amstad, P., Wyniger, J., Yilmaz, A., Fischer, J. R., Schreyer, M., & Givel, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580325 · Cited by 143
Garofalo, C., Manara, M. C., Nicoletti, G., Marino, M. T., Lollini, P., Astolfi, A., Pandini, G., López‐Guerrero, J. A., Schaefer, K.-L., Belfiore, A., et al. (2011) · Oncogene · doi:10.1038/onc.2010.640 · Cited by 138
Insulin-like growth factor II-mediated proliferation of human neuroblastoma.
El‐Badry, O. M., Helman, L. J., Chatten, J., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115042 · Cited by 137
Murphy, S. K., Huang, Z., Wen, Y., Spillman, M. A., Whitaker, R. S., Simel, L. R., Nichols, T. D., Marks, J. R., & Berchuck, A. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0138 · Cited by 136
Consequences of growth hormone (GH) overexpression and GH resistance
Bartke, A., Chandrashekar, V., Bailey, B., Zaczek, D., & Turyn, D. (2002) · Neuropeptides · doi:10.1054/npep.2002.0889 · Cited by 130
Baxter, R. C., Holman, S., Corbould, A., Stranks, S. N., Ho, P. J., & Braund, W. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7545698 · Cited by 126
Cruz-Correa, M. R., Cui, H., Giardiello, F. M., Powe, N. R., Hylind, L. M., Robinson, A., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S. A., & Wu, Y. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.051 · Cited by 125
Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells
Ingram, W. J., Wicking, C., Grimmond, S. M., Forrest, A. R. R., & Wainwright, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205975 · Cited by 125
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Gao, J., Chesebrough, J. W., Cartlidge, S. A., Ricketts, S., Incognito, L., Veldman-Jones, M. H., Blakey, D. C., Tabrizi, M. A., Jallal, B., Trail, P. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2274 · Cited by 124
Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
Lubik, A. A., Gunter, J. H., Hendy, S. C., Locke, J. A., Adomat, H. H., Thompson, V. C., Herington, A. C., Gleave, M. E., Pollak, M., & Nelson, C. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2470 · Cited by 122
Wolf, E., Kramer, R., Blum, W. F., Föll, J., & Brem, G. (1994) · Endocrinology · doi:10.1210/endo.135.5.7525257 · Cited by 119
Renehan, A. G., Jones, J., Potten, C. S., Shalet, S. M., & O’Dwyer, S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1462 · Cited by 112
Teale, J. D., & Marks, V. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00564.x · Cited by 110
Tumours producing hypoglycaemia
Marks, V., & Teale, J. D. (1998) · Endocrine Related Cancer · doi:10.1677/erc.0.0050111 · Cited by 106
Keeping IGF-II under control: Lessons from the IGF-II–IGF2R crystal structure
Brown, J., Jones, E. Y., & Forbes, B. E. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.07.003 · Cited by 104
Amit, D., & Hochberg, A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-134 · Cited by 104
Avnet, S., Sciacca, L., Salerno, M., Gancitano, G., Cassarino, M. F., Longhi, A., Zakikhani, M., Carboni, J. M., Gottardis, M. M., Giunti, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2645 · Cited by 103
Hoyo, C., Fortner, K. B., Murtha, A. P., Schildkraut, J. M., Soubry, A., Demark‐Wahnefried, W., Jirtle, R. L., Kurtzberg, J., Forman, M. R., Overcash, F. M., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9932-y · Cited by 103
Kaneda, A., Wang, C. J., Cheong, R., Timp, W., Onyango, P. O., Wen, B., Iacobuzio–Donahue, C. A., OHLSSON, R. I., Andraos, R., Pearson, M. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710359105 · Cited by 102
Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 101
Moorehead, R. A., Sanchez, O. H., Baldwin, R. M., & Khokha, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206188 · Cited by 101
Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae, S. K., Bae, M.-H., Ahn, M. Y., Son, M. J., Lee, Y. M., Bae, M., Lee, O., Park, B. C., & Kim, K. (1999) · PubMed · Cited by 99
Expression of insulin-like growth factor 2 in mesenchymal neoplasms
Steigen, S. E., Schaeffer, D. F., West, R. B., & Nielsen, T. O. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.48 · Cited by 96
Daughaday, W. H., Trivedi, B., & Baxter, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5823 · Cited by 96
Huynh, H. T., Pollak, M., & Zhang, J. C. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.1.137 · Cited by 95
Gowan, L. K., Hampton, B., Hill, D. J., et al. (1987) · Endocrinology · doi:10.1210/endo-121-2-449 · Cited by 92
Feng, Y., Zhu, Z., Xiao, X., Choudhry, V., Barrett, J. C., & Dimitrov, D. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0252 · Cited by 92
The Role of IGF-1R in Pediatric Malignancies
Kim, S. Y., Toretsky, J. A., Scher, D., & Helman, L. J. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0189 · Cited by 90
Morcavallo, A., Genua, M., Palummo, A., Kletvíková, E., Jiráček, J., Brzozowski, A. M., Iozzo, R. V., Belfiore, A., & Morrione, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252478 · Cited by 89
Ratajczak, M. Z. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0026 · Cited by 88
Changes in the IGF–IGFBP axis in critical illness
Baxter, R. C. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0161 · Cited by 86
Alajez, N. M., Shi, W., Wong, D., Lenarduzzi, M., Waldron, J. N., Weinreb, I., & Liu, F. (2012) · Oncotarget · doi:10.18632/oncotarget.785 · Cited by 85
Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
Cui, H. (2007) · Disease Markers · doi:10.1155/2007/363464 · Cited by 85
Serum Insulin-Like Growth Factor II in 44 Patients with Non-Islet Cell Tumor Hypoglycemia
Hizuka, N., Fukuda, I., Takano, K., Okubo, Y., Asakawa‐Yasumoto, K., & Demura, H. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.suppl_s61 · Cited by 84
Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells
Piecewicz, S., Pandey, A., Roy, B., Soh, H. X., Zetter, B. R., & Sengupta, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032191 · Cited by 81
Pavelić, K., Kolak, T., Kapitanović, S., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1465 · Cited by 77
Bystrom, C. E., Sheng, S., Zhang, K., Caulfield, M. P., Clarke, N. J., & Reitz, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043457 · Cited by 76
Frystyk, J., Skjærbæk, C. B., Zapf, J., & Ørskov, H. (1998) · Diabetologia · doi:10.1007/s001250050951 · Cited by 75
Pierre‐Eugène, C., Pagésy, P., Nguyen, T. T., Neuillé, M., Tschank, G., Tennagels, N., Hampe, C., & Issad, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041992 · Cited by 72
Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Alvino, C. L., Ong, S. C., McNeil, K. A., Delaine, C. A., Booker, G. W., Wallace, J. C., & Forbes, B. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027488 · Cited by 70
Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice.
Pravtcheva, D. D., & Wise, T. L. (1998) · PubMed · Cited by 70
Ellis, M. J., Leav, B. A., Yang, Z., Rasmussen, A. A., Pearce, A., Zweibel, J., Lippman, M. E., & Cullen, K. J. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.3.8833657 · Cited by 68
Eastman, R. C., Carson, R. E., Orloff, D. G., Cochran, C., Perdue, J. F., Rechler, M. M., Lanau, F., Roberts, C. T., Shapiro, J., & Roth, J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115803 · Cited by 66
Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3
Fowke, J. H., Matthews, C. E., Yu, H., Cai, Q., Cohen, S. S., Buchowski, M. S., Zheng, W., & Blot, W. J. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0023 · Cited by 64
Serrano, R., Villar, M., Martínez, C., Carrascosa, J. M., Gallardo, N., & Andrés, A. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01635 · Cited by 64
IGF2 increases de novo steroidogenesis in prostate cancer cells
Lubik, A. A., Gunter, J. H., Hollier, B. G., Ettinger, S., Fazli, L., Stylianou, N., Hendy, S. C., Adomat, H. H., Gleave, M. E., Pollak, M., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0250 · Cited by 63
Perros, P., Simpson, A. J., Innes, J. A., Teale, J. D., & McKnight, J. A. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.721542.x · Cited by 62
Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice
Pravtcheva, D. D., & Wise, T. L. (1998) · Journal of Experimental Zoology · doi:10.1002/(sici)1097-010x(19980501)281:1<43::aid-jez7>3.0.co;2-c · Cited by 62
Periconceptional nutrition and the early programming of a life of obesity or adversity
Zhang, S., Rattanatray, L., McMillen, I. C., Suter, C. M., & Morrison, J. L. (2010) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2010.12.004 · Cited by 61
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma
Gao, Y., Katki, H. A., Graubard, B. I., Pollak, M., Martin, M., Tao, Y., Schoen, R. E., Church, T. R., Hayes, R. B., Greene, M. H., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26438 · Cited by 59
Loss of Imprinting of Human Insulin-like Growth Factor II Gene, IGF2, in Acute Myeloid Leukemia
Wu, H., Weksberg, R., Minden, M. D., & Squire, J. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6127 · Cited by 56
Daughaday, W. H., & Trivedi, B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1618998 · Cited by 56
Regel, I., Eichenmüller, M., Joppien, S., Liebl, J., Häberle, B., Müller‐Höcker, J., Vollmar, A. M., von Schweinitz, D., & Kappler, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-9 · Cited by 56
Belobrajdic, D. P., Frystyk, J., Jeyaratnaganthan, N., Espelund, U. S., Flyvbjerg, A., Clifton, P. M., & Noakes, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0062 · Cited by 55
Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu, T. H., Chuyen, N. V., Li, T., & Hoffman, A. R. (2003) · PubMed · Cited by 54
Morcavallo, A., Gaspari, M., Pandini, G., Palummo, A., Cuda, G., Larsen, M. R., Vigneri, R., & Belfiore, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0484 · Cited by 54
Genomic imprinting: the influence of differential methylation in the two sexes
Biliya, S., & Bulla, L. A. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009251 · Cited by 54
Beck-Wiedemann syndrome and Wilms' tumour
Ward, A. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.2.157 · Cited by 53
Lui, J. C. K., & Baron, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219079110 · Cited by 51
Fu, V. X., Schwarze, S. R., Kenowski, M. L., LeBlanc, S. E., Svaren, J. P., & Jarrard, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405015200 · Cited by 50
Bond, J. J., Meka, S. S., & Baxter, R. C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650253 · Cited by 50
Insulin-like Growth Factors in Pediatric Health and Disease
Roith, D. L., & Butler, A. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6208 · Cited by 49
Lee, S. K., Kang, J. S., Jung, D. J., Hur, D. Y., Kim, J. E., Hahm, E., Bae, S., Kim, H. W., Kim, D., Cho, B. J., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21391 · Cited by 48
Zapf, J. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb01012.x · Cited by 47
Zhang, L., Zhan, Q., Zhan, S., et al. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.125 · Cited by 46
Hoekman, K., van Doorn, J., Gloudemans, T., Maassen, J. A., Schuller, A. G., & Pinedo, H. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00833.x · Cited by 45
Insulin-like growth factors and non-islet cell tumor hypoglycemia
Phillips, L. S., & Robertson, D. G. (1993) · Metabolism · doi:10.1016/0026-0495(93)90265-p · Cited by 45
Jeyaratnaganthan, N., Højlund, K., Kroustrup, J. P., Larsen, J. F., Bjerre, M., Levin, K., Beck‐Nielsen, H., Frago, S., Hassan, A. B., Flyvbjerg, A., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.005 · Cited by 44
Wu, K., Feskanich, D., Fuchs, C. S., Chan, A. T., Willett, W. C., Hollis, B. W., Pollak, M., & Giovannucci, E. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028520 · Cited by 43
Weber, M. M., Auernhammer, C. J., Lee, P., Engelhardt, D., & Zachoval, R. (2002) · Hormone Research in Paediatrics · doi:10.1159/000057960 · Cited by 39
Greenall, S. A., Bentley, J. D., Pearce, L. A., Scoble, J. A., Sparrow, L. G., Bartone, N. A., Xiao, X., Baxter, R. C., Cosgrove, L. J., & Adams, T. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432013 · Cited by 39
Singh, S. K., Tan, Q., Brito, C. J., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.002 · Cited by 39
Rowlands, M., Holly, J. M. P., Hamdy, F. C., Phillips, J. T., Goodwin, L., Marsden, G. L., Gunnell, D., Donovan, J., Neal, D. E., & Martin, R. M. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9883-8 · Cited by 37
The prevalence of loss of imprinting of H19 and IGF2 at birth
Rancourt, R. C., Harris, H. R., Barault, L., & Michels, K. B. (2013) · The FASEB Journal · doi:10.1096/fj.12-225284 · Cited by 37
Non‐islet cell tumour induced hypoglycaemia with acromegaloid facial and aral swelling
Trivedi, N., Mithal, A., Sharma, A. K., Mishra, S. K., Pandey, R., Trivedi, B., & Daughaday, W. H. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02654.x · Cited by 34
The Role for Insulin and Insulin-like Growth Factors in the Increased Risk of Cancer in Diabetes
LeRoith, D., Scheinman, E. J., & Bitton-Worms, K. (2011) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10043 · Cited by 34
Neuhouser, M. L., Platz, E. A., Till, C., Tangen, C. M., Goodman, P. J., Kristal, A. R., Parnes, H. L., Tao, Y., Figg, W. D., Lucia, M. S., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0250 · Cited by 34
Níkolić, J. A., Todorović, V., Božić, M., et al. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00254-5 · Cited by 31
Elmlinger, M., Sanatani, M. S., Bell, M. A., et al. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380337 · Cited by 31
Elevated free IGF2 levels in localized, early-stage breast cancer in women
Espelund, U. S., Cold, S., Frystyk, J., Ørskov, H., & Flyvbjerg, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0154 · Cited by 31
Drake, W. M., Miraki‐Moud, F., Siddiqi, A., Yateman, M., Barnes, N., Camacho-Hübner, C., & Monson, J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390532 · Cited by 30
Tani, Y., Tateno, T., Izumiyama, H., Doi, M., Yoshimoto, T., & Hirata, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-062 · Cited by 28
Yao, N., Yao, D., Wang, L., Dong, Z., Wu, W., Qiu, L., Yan, X., Yu, D., Chen, J., Sai, W., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0436-x · Cited by 28
Molecular Pathways Involved in the Antineoplastic Effects of Calcitriol on Insulinoma Cells
Galbiati, F., Polastri, L., Thorens, B., Dupraz, P., Fiorina, P., Cavallaro, U., Christofori, G., & Davalli, A. M. (2003) · Endocrinology · doi:10.1210/en.2002-221014 · Cited by 28
Daughaday, W. H., & Trivedi, B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1379260 · Cited by 27
Probst, O. C., Puxbaum, V., Svoboda, B., Leksa, V., Stockinger, H. S. J., Mikula, M., Mikulits, W., & Mach, L. (2008) · International Journal of Cancer · doi:10.1002/ijc.24236 · Cited by 27
Singh, S. K., Moretta, D., Almaguel, F. A., León, M. A. D., & León, D. D. (2008) · Growth Factors · doi:10.1080/08977190802057258 · Cited by 24
Tayebi, H. M. E., Salah, W., Sayed, I. H. E., Zekri, A. N., Zayed, N. A., Salem, S., Esmat, G., & Abdelaziz, A. I. (2011) · Biomarkers · doi:10.3109/1354750x.2011.573095 · Cited by 23
Couvert, P., Carrié, A., Pariès, J., Vaysse, J., Miroglio, A., Kerjean, A., Nahon, P., Chelly, J., Trinchet, J., Beaugrand, M., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5419 · Cited by 23
Hoyo, C., Murphy, S. K., Schildkraut, J. M., Vidal, A. C., Skaar, D. A., Millikan, R. C., Galanko, J. A., Sandler, R. S., Jirtle, R. L., & Keku, T. O. (2012) · Disease Markers · doi:10.1155/2012/492068 · Cited by 22
Mature IGF-II prevents the formation of “big” IGF-II/IGFBP-2 complex in the human circulation
Qiu, Q., Yan, X., Bell, M. D., Di, J.-M., Tsang, B. K., & Gruslin, A. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.11.001 · Cited by 20
Rikhof, B., van der Graaf, W. T. A., Suurmeijer, A. J. H., van Doorn, J., Meersma, G. J., Groenen, P. J. T. A., Schuuring, E. M. D., Meijer, C., & de Jong, S. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.028 · Cited by 19
Daragó, A., Sapota, A., Matych, J., et al. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.651 · Cited by 19
Free Insulin-Like Growth Factor (IGF) in Disorders of IGF Binding Protein 3 Complex Formation
Daughaday, W. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030882 · Cited by 17
Yoon, A. J., Zavras, A. I., Chen, M., et al. (2011) · Medical Oncology · doi:10.1007/s12032-011-9863-6 · Cited by 17
Couvert, P., Carrié, A., du Montcel, S. T., Vaysse, J., Sutton, A., Barget, N., Trinchet, J., Beaugrand, M., Ganne‐Carrié, N., Giral, P., et al. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.013 · Cited by 17
Hoyo, C., Vidal, A. C., Galanko, J., Schildkraut, J., Skaar, D. A., Murphy, S., Jirtle, R. L., Sandler, R. S., Keku, T., & Sandler, R. (2020) · Europe PMC (PubMed Central) · doi:10.3233/dma-2011-0865 · Cited by 17
Lee, S. H., Chung, Y., Kim, J. A., Lee, D., Jin, Y., Shim, J. H., Jang, M. K., Cho, E. Y., Shin, E., Lee, J., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02648.x · Cited by 15
Targeted tumor gene therapy based on loss of IGF2 imprinting
Pan, Y., He, B., Li, T., Zhu, C., Zhang, L., Bo, W., Xu, Y., Qu, L., Hoffman, A. R., Wang, S., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12442 · Cited by 12
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?
Morace, C., Cucunato, M., Bellerone, R., Caro, G. D., Crinò, S. F., Fortiguerra, A., Spadaro, F., Zirilli, A., Alibrandi, A., Consolo, P., et al. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.04.014 · Cited by 12
Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
Belharazem, D., Kirchner, M., Geissler, F., Bugert, P., Spahn, M., Kneitz, B., Riedmiller, H. N., Sauer, C. G., Küffer, S., Trojan, L., et al. (2012) · Endocrine Connections · doi:10.1530/ec-12-0054 · Cited by 11
IGF2: The Achilles' heel of p53‐deficiency?
Clermont, F. F., Nittner, D., & Marine, J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201509 · Cited by 10
IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study
Cheng, I. C., Stram, D. O., Burtt, N. P., Gianniny, L., Garcia, R. R., Pooler, L., Henderson, B. E., Marchand, L. L., & Haiman, C. A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0253 · Cited by 10
Hoogwerf, D., van Doorn, J., & Maartense, E. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012125 · Cited by 9
A case of spontaneous hypoglycaemia and impaired glucose tolerance in the same patient
Thabit, H., Healy, M. L., Royston, D., et al. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010064 · Cited by 7
Cited by
Obesity and Cancer Mechanisms: Cancer Metabolism
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9712 · Cited by 414
Advances in studies of tyrosine kinase inhibitors and their acquired resistance
Jiao, Q., Bi, L., Ren, Y., Song, S., Wang, Q., & Wang, Y.-S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0801-5 · Cited by 395
Taketo, K., Konno, M., Asai, A., Koseki, J., Toratani, M., Satoh, T., Doki, Y., Mori, M., Ishii, H., & Ogawa, K. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4219 · Cited by 356
Denduluri, S. K., Idowu, O., Wang, Z., Liao, Z., Yan, Z., Mohammed, M. K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.10.004 · Cited by 331
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Adamek, A., & Kasprzak, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051308 · Cited by 284
Metadata
- Authors
- Livingstone, C.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2013-09-30
- Volume
- 20
- Issue
- 6
- Pages
- R321-R339
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2154466664
- Cited by
- 296
- References
- 178
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.